IRADIMED CORPORATION Provides Revenue Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024
For the year, the company reiterates to report revenue of $72.0 million to $74.0 million, GAAP diluted earnings per share of $1.37 to $1.47.